该部门的科学研究是在具有丰富临床专业知识和研究成果的环境中进行的，该研究环境确保始终进行领先的临床团队对基础的科学研究具有与患者相关的洞察力，并对详细的临床问题有所了解。转化医学研究所的研究基础设施旨在使研究人员能够在最佳环境中使用世界一流的设施。我们的设施使我们能够将生物医学研究从患者样本带到实验室，反之亦然，从新生成的药物化合物进入临床试验。哲学硕士（MPhil）和医学博士（MD）2年。
The University of Liverpool has invested 20 million to support the acquisition of the Cancer Research Centre, and develop new academic posts supporting Oncology and Radiobiology to augment existing strengths within Department of Molecular and Clinical Cancer Medicine. Radiotherapy is one of the cornerstones of cancer treatment and research in the Department. We aim to develop both a greater understanding of the interaction between biological materials with radiation and to develop improved delivery of radiation for therapeutic purposes.<br><br>Scientific research in the Department is performed in an environment that has a wealth of clinical expertise and research which ensures that basic scientific research is always performed with insights of relevance to patients provided by leading clinical teams and an awareness of detailed clinical issues.<br><br>The broad range of fundamental research interests within the Department provides for world class research in cancer biology with translational links supported by world class clinical research into several major types of cancer. The Department plays a leading role in the activities of the Cancer Research UK Experimental Cancer Medicine Centre and radiation research in the Department has access to extensive radiotherapy treatment expertise including access to the proton beam facility at Clatterbridge Cancer Centre.<br><br>Radiotherapy is one of the cornerstones of cancer treatment and research in the Department aims to develop both a greater understanding of the interaction between biological materials with radiation (radiobiology) and to develop improved delivery of radiation for therapeutic purposes. Fundamental studies of the radiobiology of cancer cells and cellular responses to radiation including ionizing radiation and proton beams research in the Department benefits from the almost unique access to the proton beam facility at the Clatterbridge Cancer Centre.